Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment

The aim of the study was to evaluate the association between genetic polymorphisms of CYP2D6 and outcomes in breast cancer patients with tamoxifen treatment. We evaluated the CYP2D6 genetic polymorphisms in 766 breast cancer patients. Among them, 110 patients whose samples were prospectively collect...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyung Seok, Choi, Ji-Yeob, Lee, Mi-Jeong, Park, Seho, Yeo, Chang-Woo, Lee, Sang Seop, Shin, Jae-Gook, Park, Byeong-Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154335/
https://www.ncbi.nlm.nih.gov/pubmed/21860550
http://dx.doi.org/10.3346/jkms.2011.26.8.1007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154335/
https://www.ncbi.nlm.nih.gov/pubmed/21860550
http://dx.doi.org/10.3346/jkms.2011.26.8.1007

Ejemplares similares